A resurgence in recreational misuse of nitrous oxide has been observed in the post-coronavirus disease 2019 (COVID) pandemic era and consequently there has been a surge in cases of nitrous oxide-induced subacute combined degeneration of the cord (N2O-SACD). It is essential that physicians have an awareness of clinical history, neurologic findings, laboratory investigations, and characteristic features on MR imaging that may suggest a diagnosis of N2O-SACD. This retrospective, hospital-based case series was conducted in a tertiary medical referral center and 1 of 2 National Neuroscience Centers in Ireland. Retrieval of cases was achieved by a keyword search of a radiology PACS archive, using the terms such as "subacute combined degeneration of the cord" and "SACD" to search clinical indications for MR imaging and radiology reports at the institution from July 1, 2012 to December 31, 2024. Thirty-three patients underwent MRI investigations for suspected subacute combined degeneration of the cord. Twenty-five reported nitrous oxide use. Fourteen of those with reported nitrous oxide use and clinical symptoms had MRI findings suggestive of subacute combined degeneration of the cord. Most prominent symptoms were distal paresthesia (100%), weakness (52%), and ataxia (36%). All cases of N2O-SACD occurred between 2020 and 2024. The cervical cord was affected in all 14 MRI-positive patients with a characteristic inverted V sign synonymous with subacute combined degeneration of the cord identified in all 14 (100%). This case series reflects the growing incidence and prevalence of N2O-SACD. Presentations occurring exclusively between 2020-2024 correlate with the COVID-19 pandemic and its aftermath, which aligns with reported increased misuse across Europe at this time. MRI cervicothoracic spine with T1, T2, and STIR sagittal and T2 axial sequences should suffice for radiologic diagnosis and should be interpreted in conjunction with clinical, laboratory, and, in some cases, electrophysiologic findings.
27 March 2026 in Journal of NeuroInterventional Surgery
Background Endovascular thrombectomy (EVT) is the standard of care for large vessel occlusion stroke, yet technical failure persists in a significant minority of cases. Intracranial atherosclerotic disease (ICAD) is a recognized driver of failure in Asian populations; its prevalence in Western cohorts is underestimated. We aimed to classify mechanisms of technical failure in a large cohort and investigate the impact of both unrecognized ICAD and anatomical access difficulties. Methods We analyzed 2467 consecutive single-center EVT procedures retrospectively. Failure was defined as final modified Treatment In Cerebral Infarction (mTICI) <2b or no angiographic improvement. Failures were classified into three categories: type 1 (access failure), type 2 (clot accessed but no durable reperfusion), and type 3 (aborted/other). Type 2 failures were adjudicated by consensus to identify features suggestive of ICAD. Results Recanalization failure occurred in 313 patients (12.7%); type 1 accounted for 40 (12.8%), type 2 occurred in 127 (40.6%), and 146 (46.6%) were type 3. Baseline age and stroke severity were similar between successful and failed groups, but failure was associated with significantly longer procedure times (median 60 vs 30 min, P<0.001) and almost threefold higher in-hospital mortality (29.4% vs 11.0%, P<0.001). Among type 2 failures, 18.1% were adjudicated as likely underlying ICAD and 4.7% as possible ICAD. While overall failure rates declined from 23.0% (2012–2015) to 11.2% (2019–2023) driven by improvements in M1 middle cerebral artery recanalization, the incidence of type 1 failures did not significantly improve over time (P=0.20), representing a persistent unmet technical need. Conclusions Despite technical advances, procedural failure remains a distinct event with catastrophic outcomes. Up to 22.8% of retrieval failures in this Western cohort were attributable to likely/possible underlying ICAD rather than refractory emboli.